Is omalizumab response influenced by passive smoking in severe asthma?

D. Cavalet Blanco (Porto Alegre, Brazil), L. Martins Becher (Porto Alegre, Brazil), L. Zani Da Silva (Porto Alegre, Brazil), C. Rocha Dullius (Porto Alegre, Brazil), F. Kahan (Porto Alegre, Brazil), S. Rocha Machado (Porto Alegre, Brazil), J. Miguel Chatkin (Porto Alegre, Brazil)

Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session: Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session type: Thematic Poster
Number: 1129
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Cavalet Blanco (Porto Alegre, Brazil), L. Martins Becher (Porto Alegre, Brazil), L. Zani Da Silva (Porto Alegre, Brazil), C. Rocha Dullius (Porto Alegre, Brazil), F. Kahan (Porto Alegre, Brazil), S. Rocha Machado (Porto Alegre, Brazil), J. Miguel Chatkin (Porto Alegre, Brazil). Is omalizumab response influenced by passive smoking in severe asthma?. 1129

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: